Three Ways to Slow Down Type 2 Diabetes-Related Brain Aging

Translate to Spanish or other 102 languages!

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain.  Image for illustration purposes
Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes
- Advertisement -

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Researchers have also discovered evidence of diabetes leading to faster brain aging, which could increase the risk of Alzheimer’s. But is there a way to prevent this, and how so? In this podcast, we discuss lifestyle interventions that could help slow diabetes-related cognitive decline.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/3-lifestyle-changes-slow-down-type-2-diabetes-related-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#1

- Advertisement -

Information Source:  https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -